Mark J. Levin, Director at MILLENNIUM PHARMACEUTICALS INC (MLNM), sold 8,900 shares at $14.92 ($133K) on 2007-12-19, disclosed to the SEC on 2007-12-21.
Scheduled sale ($133k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.60 | 100 | $1K | 1.1% |
| 2 | $14.62 | 100 | $1K | 1.1% |
| 3 | $14.65 | 100 | $1K | 1.1% |
| 4 | $14.66 | 100 | $1K | 1.1% |
| 5 | $14.69 | 100 | $1K | 1.1% |
| 6 | $14.70 | 100 |
| $1K |
| 1.1% |
| 7 | $14.75 | 100 | $1K | 1.1% |
| 8 | $14.79 | 100 | $1K | 1.1% |
| 9 | $14.80 | 100 | $1K | 1.1% |
| 10 | $14.81 | 500 | $7K | 5.6% |
| 11 | $14.82 | 400 | $6K | 4.5% |
| 12 | $14.83 | 200 | $3K | 2.2% |
| 13 | $14.84 | 100 | $1K | 1.1% |
| 14 | $14.85 | 100 | $1K | 1.1% |
| 15 | $14.86 | 100 | $1K | 1.1% |
| 16 | $14.87 | 200 | $3K | 2.2% |
| 17 | $14.89 | 100 | $1K | 1.1% |
| 18 | $14.90 | 900 | $13K | 10.1% |
| 19 | $14.91 | 100 | $1K | 1.1% |
| 20 | $14.92 | 300 | $4K | 3.4% |
| 21 | $14.93 | 400 | $6K | 4.5% |
| 22 | $14.94 | 400 | $6K | 4.5% |
| 23 | $14.95 | 400 | $6K | 4.5% |
| 24 | $14.96 | 900 | $13K | 10.1% |
| 25 | $14.97 | 400 | $6K | 4.5% |
| 26 | $14.98 | 700 | $10K | 7.9% |
| 27 | $14.99 | 300 | $4K | 3.4% |
| 28 | $15.00 | 800 | $12K | 9.0% |
| 29 | $15.01 | 300 | $5K | 3.4% |
| 30 | $15.03 | 400 | $6K | 4.5% |
| Total | $14.91 avg | 8,900 | $133K | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-10 | $122K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |